Purepell

Purepell operates as a bioidentical hormone replacement therapy clinic in Frisco, Texas, focusing exclusively on hormone optimization for adults experiencing symptoms of hormonal decline or imbalance. The clinic serves patients throughout the Dallas-Fort Worth metropolitan area who seek alternatives to synthetic hormone treatments, providing individualized BHRT protocols that address testosterone deficiency, estrogen dominance, thyroid dysfunction, and adrenal insufficiency. Purepell's approach centers on laboratory-verified hormone testing followed by customized compounded bioidentical formulations designed to match each patient's specific hormonal needs rather than applying standardized dosing protocols.

The clinic's bioidentical hormone replacement programs utilize plant-derived hormones that are molecularly identical to those produced by the human body, including bioidentical estradiol, progesterone, testosterone, DHEA, and thyroid hormones. Purepell works with specialized compounding pharmacies to create personalized hormone formulations available in multiple delivery methods: sublingual troches, topical creams, subcutaneous pellets, and oral capsules. For patients experiencing andropause or low testosterone, the clinic offers testosterone replacement therapy using both pellet implants and transdermal applications, with protocols adjusted based on follow-up lab work measuring total testosterone, free testosterone, and estradiol levels. Women in perimenopause or menopause receive individualized combinations of estradiol and progesterone, with treatment plans modified according to symptom response and hormone level monitoring. The Frisco clinic also addresses thyroid optimization for patients with subclinical hypothyroidism or those inadequately managed on levothyroxine alone, incorporating T3-containing protocols when clinically indicated.

Patients at Purepell begin with comprehensive intake consultations that include detailed symptom assessments and baseline laboratory panels measuring sex hormones, thyroid function, metabolic markers, and vitamin levels. The clinic requires initial blood work to establish hormone baselines before initiating therapy, then schedules follow-up testing at specified intervals—typically six weeks after treatment initiation, then quarterly during the first year. Treatment adjustments occur based on both objective lab values and subjective symptom improvement, with providers evaluating energy levels, sleep quality, libido, mood stability, body composition changes, and cognitive function. The clinic maintains a structured follow-up schedule to monitor for potential side effects and ensure hormone levels remain within optimal therapeutic ranges rather than simply within standard reference ranges.

Purepell's patient population in Frisco includes men aged 35-70 experiencing symptoms of testosterone decline such as decreased muscle mass, increased abdominal fat, reduced libido, and mental fog, as well as women aged 40-65 dealing with hot flashes, night sweats, mood changes, vaginal dryness, and sleep disturbances related to estrogen and progesterone fluctuations. The clinic also treats younger patients with documented hormone deficiencies resulting from medical conditions, surgical menopause, or premature ovarian insufficiency. Treatment duration varies by individual, with some patients requiring ongoing hormone support indefinitely while others use BHRT as a bridge therapy during specific life transitions.

Located in Frisco, Texas, Purepell operates within the rapidly growing northern Dallas suburbs, providing hormone therapy services to residents of Collin County and surrounding communities including Plano, McKinney, Allen, and Prosper. The clinic's focus on bioidentical formulations rather than conventional hormone replacement distinguishes its approach from traditional endocrinology practices, appealing to patients who prefer hormones derived from plant sources and customized to individual needs. With a 5.0-star rating from patient reviews, the clinic has established a reputation for thorough hormone management and responsive adjustments to treatment protocols based on patient feedback and laboratory monitoring.